About 250 Mg Abiraterone Acetate Tablets IP
Experience the dazzling efficacy of 250 Mg Abiraterone Acetate Tablets IP, celebrated for their role in advanced prostate cancer treatment. Featuring an immaculate salt composition of Abiraterone Acetate and crafted in India, these tablets are available for your procurement as a distributor, exporter, supplier, or trader. With a shelf life of up to 24 months and storage instructions for a dry place, this featured product provides a last chance to access quality medication that meets rigorous global standards. Secure your supply and empower better patient outcomes today.
Applications and Uses of 250 Mg Abiraterone Acetate Tablets IP
250 Mg Abiraterone Acetate Tablets IP are used primarily for the treatment of metastatic prostate cancer. Specifically, they are indicated in cases where hormonal therapies are required. The general use is within oncology settings, with the site of application being oral administration under medical supervision. Their targeted mechanism aids in reducing androgen production, making them a preferred choice for improving patient health outcomes.
Trade Availability and Export Details for Abiraterone Acetate Tablets
Order completion for the 250 Mg Abiraterone Acetate Tablets IP is processed through approved purchase orders at your specified asking price. FOB ports in prominent Indian cities facilitate swift export logistics. Samples are available upon request, supporting informed procurement decisions. Our main export markets span Asia, Africa, and the Middle East, ensuring international clients receive celebrated quality with every procurement cycle.
FAQ's of 250 Mg Abiraterone Acetate Tablets IP:
Q: How should 250 Mg Abiraterone Acetate Tablets IP be stored for optimal shelf life?
A: To maintain their efficacy and quality, these tablets should be stored in a dry place, away from moisture and direct sunlight, ensuring a shelf life of up to 24 months.
Q: What is the recommended usage for Abiraterone Acetate Tablets IP?
A: The tablets are prescribed mainly for advanced prostate cancer and should be taken orally as directed by a healthcare professional within oncology treatment protocols.
Q: When is it suitable to procure these tablets for export or distribution?
A: Abiraterone Acetate Tablets IP are available for procurement year-round, with highlighted featured offerings providing a last chance for bulk acquisitions during select periods.
Q: Where are the main export markets for 250 Mg Abiraterone Acetate Tablets IP?
A: The main export markets include Asia, Africa, and the Middle East, where celebrated Indian pharmaceutical quality is highly sought after.
Q: What is the process for requesting a sample of these tablets before placing a purchase order?
A: Interested clients can request samples, which are dispatched upon inquiry and order completion approval, aiding in quality assessment and informed purchasing decisions.
Q: How does using Abiraterone Acetate Tablets IP benefit patients with prostate cancer?
A: These tablets help reduce androgen production in patients, potentially leading to improved disease management and extended survival rates in advanced prostate cancer cases.